Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DR. REDDYS LAB ALKEM LABORATORIES/
DR. REDDYS LAB
 
P/E (TTM) x 32.4 20.1 161.0% View Chart
P/BV x 4.2 3.8 110.5% View Chart
Dividend Yield % 1.1 0.7 162.6%  

Financials

 ALKEM LABORATORIES   DR. REDDYS LAB
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
DR. REDDYS LAB
Mar-22
ALKEM LABORATORIES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4,0685,614 72.5%   
Low Rs2,6713,655 73.1%   
Sales per share (Unadj.) Rs889.41,294.6 68.7%  
Earnings per share (Unadj.) Rs140.5126.9 110.7%  
Cash flow per share (Unadj.) Rs166.0196.9 84.3%  
Dividends per share (Unadj.) Rs34.0030.00 113.3%  
Avg Dividend yield %1.00.6 155.9%  
Book value per share (Unadj.) Rs722.41,145.8 63.0%  
Shares outstanding (eoy) m119.57166.43 71.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.83.6 105.8%   
Avg P/E ratio x24.036.5 65.7%  
P/CF ratio (eoy) x20.323.5 86.3%  
Price / Book Value ratio x4.74.0 115.3%  
Dividend payout %24.223.6 102.3%   
Avg Mkt Cap Rs m402,868771,272 52.2%   
No. of employees `000NANA-   
Total wages/salary Rs m19,62738,858 50.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,342215,452 49.4%  
Other income Rs m1,6274,847 33.6%   
Total revenues Rs m107,968220,299 49.0%   
Gross profit Rs m20,38037,674 54.1%  
Depreciation Rs m3,04011,652 26.1%   
Interest Rs m524958 54.7%   
Profit before tax Rs m18,44329,911 61.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6408,789 18.7%   
Profit after tax Rs m16,80321,122 79.6%  
Gross profit margin %19.217.5 109.6%  
Effective tax rate %8.929.4 30.3%   
Net profit margin %15.89.8 161.2%  
BALANCE SHEET DATA
Current assets Rs m84,354177,880 47.4%   
Current liabilities Rs m48,05397,658 49.2%   
Net working cap to sales %34.137.2 91.7%  
Current ratio x1.81.8 96.4%  
Inventory Days Days4256 75.3%  
Debtors Days Days65113 57.2%  
Net fixed assets Rs m43,245106,819 40.5%   
Share capital Rs m239832 28.7%   
"Free" reserves Rs m86,134189,859 45.4%   
Net worth Rs m86,373190,691 45.3%   
Long term debt Rs m945,746 1.6%   
Total assets Rs m127,599284,699 44.8%  
Interest coverage x36.232.2 112.4%   
Debt to equity ratio x00 3.6%  
Sales to assets ratio x0.80.8 110.1%   
Return on assets %13.67.8 175.1%  
Return on equity %19.511.1 175.6%  
Return on capital %21.915.7 139.6%  
Exports to sales %18.747.1 39.8%   
Imports to sales %018.8 0.0%   
Exports (fob) Rs m19,924101,544 19.6%   
Imports (cif) Rs mNA40,401 0.0%   
Fx inflow Rs m19,924101,544 19.6%   
Fx outflow Rs m3,91140,401 9.7%   
Net fx Rs m16,01361,143 26.2%   
CASH FLOW
From Operations Rs m11,11028,108 39.5%  
From Investments Rs m-14,351-26,387 54.4%  
From Financial Activity Rs m3,796-2,422 -156.7%  
Net Cashflow Rs m58032 1,811.3%  

Share Holding

Indian Promoters % 57.2 26.7 214.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.9 50.7 41.1%  
FIIs % 4.4 27.3 16.2%  
ADR/GDR % 0.0 10.5 -  
Free float % 42.8 62.8 68.2%  
Shareholders   76,516 246,788 31.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    CIPLA    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Dr. Reddys Share Price Performance

Period ALKEM LABORATORIES Dr. Reddys S&P BSE HEALTHCARE
1-Day 0.78% 0.61% -0.32%
1-Month 1.14% 2.66% -2.40%
1-Year -14.02% 0.91% -8.59%
3-Year CAGR 8.97% 11.77% 17.75%
5-Year CAGR 6.39% 15.06% 9.32%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.2% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

Dr. Reddys paid Rs 30.0, and its dividend payout ratio stood at 23.6%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Adani Group's Port Acquisition | Why Defence Stocks are Falling | Top Buzzing Stocks Today Adani Group's Port Acquisition | Why Defence Stocks are Falling | Top Buzzing Stocks Today(Pre-Open)

On Wednesday, Indian share markets witnessed high volatility as Adani group stocks and insurance companies fell sharply in the second half, dampening overall sentiment.